Comparison of Newer Colonoscopy Devices With Standard Forward Viewing (SFV) Colonoscopes in Daily Practice
1 other identifier
interventional
4,114
0 countries
N/A
Brief Summary
Retrospective data analysis of comparsion of 3 types of colonoscopes in daily practice (FUSE Full spectrum colonoscopy with 330° angle of view vs Pentax standard HD-colonoscopes and Pentax plus Endocuff): medical device of the category IIb (CE-marked device used within its intended purpose)
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Mar 2015
Longer than P75 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 25, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
September 25, 2019
CompletedFirst Submitted
Initial submission to the registry
July 11, 2020
CompletedFirst Posted
Study publicly available on registry
July 15, 2020
CompletedFebruary 10, 2021
February 1, 2021
4.6 years
July 11, 2020
February 8, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
Adenoma detection rate
adenoma counts
within 45 minutes of examination
Secondary Outcomes (1)
time for endoscopy (time to ileum, withdrawal and intervention time). Medication, Satisfaction on VAS
within 45 minutes of examination
Study Arms (3)
FUSE
OTHERwide angle colonoscope
HD Pentax i10 colonoscopes
OTHERSFV instrument
Endocuff
OTHERCuff on SFV
Interventions
patients have been randomly assigned for colonoscopy with FUSE or HD SFV endoscopes with or without Endocuff
Eligibility Criteria
You may qualify if:
- all patient fit for ambulatory colonoscopy
You may not qualify if:
- for Endocuff stricturing divertculosis
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Geyer Martin, Director and Principal investigator
Study Record Dates
First Submitted
July 11, 2020
First Posted
July 15, 2020
Study Start
March 1, 2015
Primary Completion
September 25, 2019
Study Completion
September 25, 2019
Last Updated
February 10, 2021
Record last verified: 2021-02
Data Sharing
- IPD Sharing
- Will not share